Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

L6 myoblast differentiation is modulated by Cdk5 via the PI3K–AKT–p70S6K signaling pathway

Abstract

Cdk5 regulates myogenesis but the signaling cascade through which Cdk5 modulates this process remains to be characterized. Here, we investigated whether PI3K, Akt, p70S6K, p38 MAPK, p44/42 MAPK, and Egr-1 serve as upstream regulators of Cdk5 during L6 myoblast differentiation. Upon serum reduction, we found that besides elevated expression of Cdk5 and its activator, p35, and increased Cdk5/p35 activity, Egr-1, Akt, p70S6K, and p38 MAPK activity were upregulated in differentiating L6 cells. However, p44/42 MAPK was downregulated and SAPK/JNK was unaffected. LY294002, a PI3K inhibitor, blocked the activation of Akt and p70S6K, indicating that Akt and p70S6K activation is linked to PI3K activation. The lack of LY294002 effect on p38 MAPK suggests that p38 MAPK activation is not associated with PI3K activation. Rapamycin, a specific inhibitor of FRAP/mTOR (the upstream kinase of p70S6K), also blocked p70S6K activation, indicating the involvement of FRAP/mTOR activation. LY294002 and rapamycin also blocked the enhancement of Egr-1 level, Cdk5 activity, and myogenin expression, suggesting that upregulation of these factors is coupled to PI3K–p70S6K activation. Overexpression of dominant-negative-Akt also reduced Cdk5/p35 activity and myogenin expression, indicating that the PI3K–p70S6K–Egr-1–Cdk5 signaling cascade is linked to Akt activation. SB2023580, a p38 MAPK inhibitor, had no effect on p70S6K, Egr-1, or Cdk5 activity, suggesting that p38 MAPK activation lies in a pathway distinct from the PI3K–Akt–p70S6K–Egr-1 pathway that we identify as the upstream modulator of Cdk5 activity during L6 myoblast differentiation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Remesy C, Chap H and Payrastre B . (1997). Biochem. Pharmacol., 53, 1649–1657.

  • Arnold HH, Braun T, Bober E, Buchberger A, Winter B and Salminen A . (1992). Symp. Soc. Exp. Biol., 46, 37–51.

  • Cao XM, Koski RA, Gashler A, McKiernan M, Morris CF, Gaffney R, Hay RV and Sukhatme VP . (1990). Mol. Cell Biol., 10, 1931–1939.

  • Chen F and Studzinski GP . (2001). Blood, 97, 3763–3767.

  • Chung J, Grammer TC, Lemon KP, Kazlauskas A and Blenis J . (1994). Nature (London), 370, 71–75.

  • Conejo R, Alvaro C, Benito M, Cuadrado A and Lorenzo M . (2002). Oncogene, 21, 3739–3753.

  • Coolican SA, Samuel DS, Ewton DZ, Clade FJ and Florini JR . (1997). J. Biol. Chem., 272, 6653–6662.

  • Datta K, Bellacosa A, Chan TO and Tsichlis PN . (1996). J. Biol. Chem., 271, 30835–30839.

  • Davies SP, Reddy H, Caivano M and Cohen P . (2000). Biochem. J., 351, 95–105.

  • Dhavan R and Tsai LH . (2001). Nat. Rev. Mol. Cell Biol., 10, 749–759.

  • Gao CY, Zakeri Z, Zhu Y, He H and Zelenka PS . (1997). Dev. Genet., 20, 267–275.

  • Gredinger E, Gerber AN, Tamir Y, Tapscott SJ and Bengal E . (1998). J. Biol. Chem., 273, 10436–10444.

  • Guidato S, McLoughlin DM, Grierson AJ and Miller CC . (1998). J. Neurochem., 70, 335–340.

  • Han JW, Pearson RB, Dennis PB and Thomas G . (1995). J. Biol. Chem., 270, 21396–21403.

  • Harada S, Esch GL, Holgado-Madruga M and Wong AJ . (2001a). DNA Cell Biol., 20, 223–229.

  • Harada T, Morooka T, Ogawa S and Nishida E . (2001b). Nat. Cell Biol., 3, 453–459.

  • Jones NC, Fedorov YV, Rosenthal RS and Olwin BB . (2001). J. Cell Physiol., 186, 104–115.

  • Kim S, Jung Y, Kim D, Koh H and Chung J . (2000). J. Biol. Chem., 275, 25979–25984.

  • Kitzmann M and Fernandez A . (2001). Cell. Mol. Life Sci., 58, 571–579.

  • Konishi H, Matsuzaki H, Tanaka M, Ono Y, Tokunaga C, Kuroda S and Kikkawa U . (1996). Proc. Natl. Acad. Sci. USA, 93, 7639–7643.

  • Laprise P, Poirier EM, Vezina A, Rivard N and Vachon PH . (2002). J. Cell Physiol., 191, 69–81.

  • Lazaro JB, Kitzmann M, Poul MA, Vandromme M, Lamb NJ and Fernandez A . (1997). J. Cell Sci., 110, 1251–1260.

  • Lechner C, Zahalka MA, Giot JF, Moller NP and Ullrich A . (1996). Proc. Natl. Acad. Sci. USA, 93, 4355–4359.

  • Lee K-Y, Qi Z, Yu YP and Wang JH . (1997). Int. J. Biochem. Cell Biol., 29, 951–958.

  • Lee K-Y, Rosales JL, Tang D and Wang JH . (1996). J. Biol. Chem., 271, 1538–1543.

  • Lew J and Wang JH . (1995). Trends Biochem. Sci., 20, 33–37.

  • Liu JW, Lacy J, Sukhatme VP and Coleman DL . (1991). J. Biol. Chem., 266, 5929–5933.

  • Miyajima M, Nornes HO and Neuman T . (1995). NeuroReport, 6, 1130–1136.

  • Morgan DO . (1997). Annu. Rev. Cell Dev. Biol., 13, 261–291.

  • Moule SK, Welsh GI, Edgell NJ, Foulstone EJ, Proud CG and Denton RM . (1997). J. Biol. Chem., 272, 7713–7719.

  • Ostrovsky O and Bengal E . (2003). J. Biol. Chem., 278, 21221–21231.

  • Philpott A, Porro EB, Kirschner MW and Tsai LH . (1997). Genes Dev., 11, 1409–1421.

  • Reif K, Burgering BM and Cantrell DA . (1997). J. Biol. Chem., 272, 14426–14433.

  • Reusch HP, Zimmermann S, Schaefer M, Paul M and Moelling K . (2001). J. Biol. Chem., 276, 33630–33637.

  • Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD and Glass DJ . (1999). Science, 286, 1738–1741.

  • Rosales JL, Lee BC, Modarressi M, Sarker K, Lee KY, Jeong YG, Oko R and Lee K-Y . (2004). J. Biol. Chem., 279, 1224–1232.

  • Sable CL, Flippase N, Hemming B and Van Obberghen E . (1997). FEBS Lett., 409, 253–257.

  • Sarker KP, Biswas KK, Yamakuchi M, Lee K-Y, Hahiguchi T, Kracht M, Kitajima I and Maruyama I . (2003). J. Neurochem., 85, 50–61.

  • Sarker KP, Nakata M, Kitajima I, Nakajima T and Maruyama I . (2000). J. Mol. Neurosci., 15, 243–250.

  • Scheid MP, Marignani PA and Woodgett JR . (2002). Mol. Cell Biol., 22, 6247–6260.

  • Tamir Y and Bengal E . (2000). J. Biol. Chem., 275, 34424–34432.

  • Tureckova J, Wilson EM, Cappalonga JL and Rotwein P . (2001). J. Biol. Chem., 276, 39264–39270.

  • Winter B and Arnold HH . (2000). J. Cell Sci., 113, 4211–4220.

  • Xiong Y, Zhang H and Beach D . (1992). Cell, 71, 505–514.

  • Zetser A, Frank D and Bengal E . (2001). Dev. Biol., 240, 168–181.

  • Zhang H, Xiong Y and Beach D . (1993). Mol. Biol. Cell, 9, 897–906.

Download references

Acknowledgements

We thank Dr Jim Woodgett (University of Toronto) for providing the mutant and wild-type Akt expressing plasmids. We also thank Dr Ji Won Yoon (University of Calgary) for providing us L6 cells. KPS is an Alberta Cancer Board postdoctoral fellow. This work was supported by a grant from the Canadian Institutes of Health Research (CIHR) to KYL, an Alberta Heritage Foundation for Medical Research (AHFMR) Senior Scholar.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ki-Young Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarker, K., Lee, KY. L6 myoblast differentiation is modulated by Cdk5 via the PI3K–AKT–p70S6K signaling pathway. Oncogene 23, 6064–6070 (2004). https://doi.org/10.1038/sj.onc.1207819

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207819

Keywords

This article is cited by

Search

Quick links